Literature DB >> 2481593

An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules.

B Culmann1, E Gomard, M P Kiény, B Guy, F Dreyfus, A G Saimot, D Sereni, J P Lévy.   

Abstract

By using target cells that expressed only the regulatory NEF protein of the human immunodeficiency virus (HIV), we were able to identify specific cytolytic T cells (CTL) from most of the seropositive patients tested. This NEF-specific cytolytic activity was mediated by CD8+ lymphocytes. In two different donors, we identified a unique peptide in the NEF protein that could be recognized in association with two different HLA class I molecules. The definition of such a peptide should prove useful in evaluating vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481593     DOI: 10.1002/eji.1830191231

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

2.  Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.

Authors:  Sharilyn Almodovar; Rob Knight; Amanda A Allshouse; Sarah Roemer; Catherine Lozupone; Daniel McDonald; Jeremy Widmann; Norbert F Voelkel; Robert J Shelton; Edu B Suarez; Kenneth W Hammer; Cecile Goujard; Nicola Petrosillo; Gerald Simonneau; Priscilla Y Hsue; Marc Humbert; Sonia C Flores
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-17       Impact factor: 2.205

Review 3.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line.

Authors:  P E Harris; A I Colovai; A Maffei; Z Liu; N S Foca
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  Computer simulations to predict the availability of peptides with known HLA class I motifs possibly generated by proteolysis of HIV-1 proteins in infected cells.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

7.  Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).

Authors:  E G Hulskotte; A M Geretti; K H Siebelink; G van Amerongen; M P Cranage; E W Rud; S G Norley; P de Vries; A D Osterhaus
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates.

Authors:  M J Irwin; L S Laube; V Lee; M Austin; S Chada; C G Anderson; K Townsend; D J Jolly; J F Warner
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

Authors:  M C Aldhous; K C Watret; J Y Mok; A G Bird; K S Froebel
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

Authors:  Y Yasutomi; K A Reimann; C I Lord; M D Miller; N L Letvin
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.